2103 results
Generalized Tardive Dyskinesia on Physical Exam

Generalized Tardive Dyskinesia after 20 years of treatment with antipsychotics for
antipsychotics for schizophrenia ... PhysicalExam #clinical #video
Waxy Flexibility in Catatonia

Catatonia is a psychomotor condition characterized by the total loss of motor initiative,
associated with schizophrenia ... Catatonia #clinical #video
Schizophrenia spectrum disorders
Schizoaffective disorder 
•	is Schizophreniform/Schizophrenia plus Manic or depressive symptoms. 
•	Key is the finding of
Schizophrenia spectrum ... Schizophreniform/Schizophrenia ... Schizophreniform/Schizophrenia ... Schizophreniform/Schizophrenia ... disorder #Schizophrenia
Schizophrenia: Pathogenesis and Symptoms
Increased dopaminergic transmission in mesolimbic projection
-> Dopaminergic neurons here project into the limbic
Schizophrenia: Pathogenesis ... Positive Symptoms of Schizophrenia ... usually auditory in schizophrenia ... Negative Symptoms of Schizophrenia ... asociality #Schizophrenia
Long-Acting Injectable (LAI) - Atypical Antipsychotics 
INVEGA TRINZA 3 MONTHS 
ARISTADA 2 MONTHS 
INVEGA 1 MONTH
SUSTENNA
the treatment of schizophrenia ... having uncontrolled schizophrenia
Dizziness - Differential Diagnosis Framework
Vertigo:
 • Peripheral: Labyrinthitis, BPPV, Meniere's disease, Alternobaric
 • Central: CVA/TIA -
Panic disorder, Schizophrenia
Carbamazepine Toxicity

Carbamazepine (CBZ) is an antiepileptic drug commonly prescribed for seizure disorders, trigeminal neuralgia, neuropathic pain,
neuropathic pain, schizophrenia
Psychotic Disorders - Differential Diagnosis Algorithm

Mood disorder with psychotic features
 • Psychotic symptoms present exclusively during
illness 1-6 months Schizophrenia
Drugs for Depression and Anxiety Disorders

Selective Serotonin Reuptake Inhibitors
 • Citalopram, Escitalopram, Fluoxetine, Fluvoxamine, Paroxetine, Sertraline,
disorders • Schizophrenia
Clozapine Toxicology
Clozapine is an atypical antipsychotic most often reserved for use in patients who have treatment-resistant
treatment-resistant schizophrenia